• 我要登录|
  • 免费注册
    |
  • 我的丁香通
    • 企业机构:
    • 成为企业机构
    • 个人用户:
    • 个人中心
  • 移动端
    移动端
丁香通 logo丁香实验_LOGO
搜实验

    大家都在搜

      大家都在搜

        0 人通过求购买到了急需的产品
        免费发布求购
        发布求购
        点赞
        收藏
        wx-share
        分享

        In vitro Assessment of Transporter-Mediated Uptake in Plated Cryopreserved Hepatocytes

        互联网

        554

        实验设备

         

        37°C water bath

        37°C / 5% CO2 humidified incubator

        Orbital shaker placed inside incubator

        实验步骤

         

        1. Prepare compound stocks: test articles (TA) and positive control(s) (PC) dissolved in an organic solvent such as methanol or DMSO to desired concentration, such as 1 mM.

        2. In separate conical tubes, add the test compounds and positive control(s) to warm Incubation Medium to yield the desired working concentration(s). For example, prepare 1 μM by adding 20 μL of 1 mM test article stock solution to 20 mL of Incubation Medium. Note: if DMSO is used as a solvent, the concentration should not exceed 0.1%, with a maximum of 1% in the final Incubation Medium.

        3. Remove the wash medium from the hepatocytes and replace with an appropriate volume of Incubation Medium containing the TA or PC for the appropriate time point. Incubate on an orbital shaker for 0, 1, 2, 4, 6 and 8 hr at 80-120 rpm for a 24-well plate. Some low-turnover compounds typically require up to 24 hr incubation periods.

        4. Stop the incubations by addition of the appropriate quenching solvent. Mix briefly and collect samples and eithe  freeze at -70°C, or directly extract as per analytical methods. If plate is to be returned to incubator, aspirate remaining quenching solvent.

        5. Analyze parent disappearance (and metabolite formation as desired) by analytical method(s) of choice, typically HPLC or LC-MS/MS.

        6. Determine the in vitro half-life (t1/2 ) of the parent compound by regression analysis of the percent parent disappearance vs. time curve.

        7. Intrinsic clearance in vitro (Clint in vitro ) can be calculated according to the equation: Clint in vitro = kV/N, where k = 0.693/t1/2, V = incubation volume and N = number of hepatocytes per well (Table 1).

        8. Clint in vitro may be scaled to in vivo predictions according to Obach and McGinnity.

        Table 1.  Parameters used in intrinsic clearance in vitro (Clint,in vitro) calculations for human hepatocytes. The assumption for N is that all hepatocytes adhered to the well with respect to seeding density.

        Plate format

        Seeding density (106  total cells/mL)

        Incubation volume V (mL)

        Hepatocytes per well N (106  cells)

        12-well

        Either 0.7 / 0.8 / 0.9

        1.0

        0.7 / 0.8 / 0.9

        24-well

        Either 0.7 / 0.8 / 0.9

        0.5

        0.35 / 0.4 / 0.45

        48-well

        Either 0.7 / 0.8 / 0.9

        0.2

        0.14 / 0.16 / 0.18

        96-well

        Either 0.7 / 0.8 / 0.9

        0.1

        0.07 / 0.08 / 0.09

         

        注意事项

         

        Review this protocol, as well as the protocol, Thawing and Use of Plateable and Suspension Cryopreserved Hepatocytes, to ensure you have all the necessary reagents and equipment prior to starting the procedure. Once thawed, cryopreserved hepatocytes must be used immediately and will not maintain viability if refrozen.

        Use universal safety precautions and appropriate biosafety cabinet when handing primary hepatocytes.

        ad image
        提问
        扫一扫
        丁香实验小程序二维码
        实验小助手
        丁香实验公众号二维码
        扫码领资料
        反馈
        TOP
        打开小程序